Cadence Pharmaceuticals Financial Statements
Cadence Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Cadence Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (54.2) | (53.6) | (7.8) |
| Total Net Income ($ mil.) | (51.7) | (52.2) | (7.5) |
| Diluted EPS (Net Income) | (1.81) | (10.07) | (1.63) |
Cadence Pharmaceuticals Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (15.6) | (13.8) | (14.6) |
| Total Net Income ($ mil.) | (15.6) | (13.7) | (14.2) |
| Diluted EPS (Net Income) | (0.41) | (0.42) | (0.50) |
Cadence Pharmaceuticals Stock Quote & Chart
09/08/08 09:00:18 EST •
NASDAQ •
9.99
•
 -0.0100
•
-0.1000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Cadence Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 3.53 | 1.56 |
| Price/Earnings Ratio | -- | 15.32 | 15.80 |
| Price/Book Ratio | 7.38 | 2.96 | 1.51 |
| Price/Cash Flow Ratio | -- | 12.69 | 9.70 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Cadence Pharmaceuticals Financial Ratios
Cadence Pharmaceuticals Competitive Intelligence
| Endo Pharmaceuticals | Johnson & Johnson | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1,085.6 | 61,095.0 | 48,418.0 |
| Employees | 1,208 | 119,200 | 86,600 |
| Market Cap ($ mil.) | 2,785.3 | 198,797.7 | 128,618.2 |
Competitive Landscape
